Eli Lilly's experimental obesity drug shows over 11% weight loss in early trial

Published on 14/06/2025 at 04:09

Reuters

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Eli Lilly and Company

Many US employers plan to pare health benefits as weight-loss spending soars	18/07	RE
Trump Reportedly Says New Pharmaceutical Tariffs Likely by July-End	16/07	MT
Biocon eyes generic Wegovy obesity drug launch in India, Canada in next 2 years, CEO says	16/07	RE
Health Canada Expands Eli Lilly's Omvoh Indication to Crohn's, Approves Citrate-Free Formula	16/07	MT
Kailera touts late-stage win for weight-loss drug in China	15/07	RE
Health Rounds: Experimental Bayer drug eases menopause-like symptoms from breast cancer therapy	11/07	RE
FDA May Fast Track Drug Reviews for Lower US Prices	11/07	MT
FDA May Fast Track Drug Reviews for Lower US Prices, Bloomberg Reports	11/07	MT
Guggenheim Adjusts Eli Lilly and Co.'s Price Target to $942 From $936, Keeps Buy Rating	11/07	MT
Wall Street Waits to Hear the Numbers	11/07
Eli Lilly and Co (India) with Association of Physicians of India announces launch of API - Obesity Gurukul - statement	11/07	RE
Morgan Stanley Adjusts Price Target on Eli Lilly to $1,135 From $1,133, Maintains Overweight Rating	10/07	MT
Sector Update: Health Care Stocks Higher Late Afternoon	10/07	MT
Sector Update: Health Care	10/07	MT
Öhman Health and New Technology Fund Rises 3.9% in June - Camurus Surges After Eli Lilly Partnership	09/07	FW
Eli Lilly Seen Benefiting From Higher Zepbound Sales in Q2, BofA Says	09/07	MT
Eli Lilly: new recommended dosage for Kisunla	09/07
Eli Lilly and Company Announces FDA Approves Updated Label for Lilly's Kisunla (donanemab-azbt) with New Dosing in Early Symptomatic Alzheimer's Disease	09/07	CI
Eli Lilly Gets FDA Approval for Updated Kisunla Dosing for Alzheimer's	09/07	MT
Eli Lilly FDA approves updated label for Kisunla	09/07	RE
US FDA approves gradual dosing for Lilly Alzheimer's drug	09/07	RE
Trump says pharmaceutical tariffs could reach 200%	09/07	RE
Pharma Stocks Pare Gains After Trump Reportedly Threatens 200% Tariff on Imported Drugs	08/07	MT
WeightWatchers names new medical chief, plans to offer menopause therapy and support	08/07	RE
Sector Update: Tech	08/07	MT